Sequenom: Breadth of ‘540 Patent Creates Vulnerability to Validity Challenge Despite Strength of Claims

March 2, 2012 – In The News
BioPharm Insight

Gerard Norton's comments appeared in a BioPharm Insight article regarding litigation between Sequenom (US Patent No. 6,258,540) and Aria Diagnostics and Natera for infringing its noninvasive trisomy 21 and paternity tests patents involving non-invasive prenatal diagnosis of Down Syndrome.

Norton discusses the validity of Sequenom's patent filing as well as the litigation issues involved.

Additional Information